Bayesian network meta-analysis of 8 RCTs (10 644 patients with HFpEF/HFmrEF): only finerenone reduced HF hospitalisation vs placebo (RR 0.84); spironolactone and eplerenone were non-significant; no MRA reduced CV death; finerenone and spironolactone increased hyperkalaemia.
Meta-analysisn = 10,644
Bagattoli et al. Finerenone, eplerenone, and spironolactone in heart failure with preserved ejection fraction: a Bayesian network meta-analysis of efficacy and safety